MAPT and Cognitive impairment: Previous research has shown that administering DSP4 to P301S tau transgenic mice for 4 or 6 months worsened tau pathology, including tau aggregation, neuronal loss, and cognitive impairments (Chalermpalanupap et al., 2017).